Diversified Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

Diversified Trust’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,450	Closed	-$213K	–	374
2019 Q2	$213K	Buy	6,450 +500	+8%	+$17.1K	0.01%	339
2019 Q1	$208K	Buy	+5,950	New	+$221K	0.01%	326
2018 Q4	–	Sell	-4,850	Closed	-$244K	–	363
2018 Q3	$244K	Hold	4,850	–	–	0.01%	284
2018 Q2	$290K	Buy	4,850 +250	+5%	+$13K	0.02%	242
2018 Q1	$211K	Buy	+4,600	New	+$192K	0.01%	284

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

ACM

Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

Diversified Trust's SUPN Position: Q3 2019 in Review

Diversified Trust sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 6,450 shares — an estimated $213K sold.

Diversified Trust first reported a position in SUPN in Q1 2018 and held it in 5 quarters. The position peaked at $290K in Q2 2018. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

Diversified Trust reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Diversified Trust sold 6,450 Supernus Pharmaceuticals shares in Q3 2019, an estimated $213K.
Diversified Trust first reported a position in Supernus Pharmaceuticals in Q1 2018 and held it in 5 quarters.
Diversified Trust's Supernus Pharmaceuticals position peaked at $290K in Q2 2018.
243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Diversified Trust's 13F filing for Q3 2019, filed 9 Oct 2019.